FFCP PHASE1:Mm9::chr7:135409851..135409862,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=246787|HGNC=|MCL_coexpression_id=11|UniProt=|association_with_transcript=0bp_to_ENSMUST00000153418_5end|description=CAGE_peak_3_at_Slc5a2_5end|id=chr7:135409851..135409862,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002113!6.37e-36!14;UBERON:0003918!6.37e-36!14;UBERON:0005095!6.37e-36!14;UBERON:0007687!6.37e-36!14;UBERON:0006554!2.44e-31!16;UBERON:0001008!1.89e-29!17;UBERON:0000489!1.09e-23!21;UBERON:0003103!4.14e-11!43;UBERON:0005172!1.25e-09!49;UBERON:0005173!1.25e-09!49;UBERON:0002417!1.25e-09!49;UBERON:0000916!1.25e-09!49;UBERON:0009569!6.93e-07!66|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.06e-22,14;UBERON:0003918,1.06e-22,14;UBERON:0011143,1.06e-22,14;UBERON:0005095,1.06e-22,14;UBERON:0007687,1.06e-22,14;UBERON:0006554,9.33e-18,18;UBERON:0001008,7.63e-17,19;UBERON:0000489,2.81e-15,21;UBERON:0003103,1.31e-07,43|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.04103896362567,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.842666520790511,0,0,0,0,0,0,0,0,0,0,1.25602267690966,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228497025219458,1.1270773567308,0.407302655690628,0.387904974335251,0.771494018793504,6.70307293517127,16.5323365737154,17.1128613347099,24.4326384565165,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147198920134397,0,0,0,0,0,0,0,0,0,0,0,0.0985044823755635,0,0,0,0,0,0,0,0,0|short_description=p3@Slc5a2}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:246787 | |||
|HGNC= | |||
|MCL_coexpression_id=11 | |||
|TSSclassifier=NA | |||
|UniProt= | |||
|association_with_transcript=0bp_to_ENSMUST00000153418_5end | |||
|cluster_id=chr7:135409851..135409862,+ | |||
|description=CAGE_peak_3_at_Slc5a2_5end | |||
|id=chr7:135409851..135409862,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002113!6.37e-36!14;UBERON:0003918!6.37e-36!14;UBERON:0005095!6.37e-36!14;UBERON:0007687!6.37e-36!14;UBERON:0006554!2.44e-31!16;UBERON:0001008!1.89e-29!17;UBERON:0000489!1.09e-23!21;UBERON:0003103!4.14e-11!43;UBERON:0005172!1.25e-09!49;UBERON:0005173!1.25e-09!49;UBERON:0002417!1.25e-09!49;UBERON:0000916!1.25e-09!49;UBERON:0009569!6.93e-07!66 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.06e-22,14;UBERON:0003918,1.06e-22,14;UBERON:0011143,1.06e-22,14;UBERON:0005095,1.06e-22,14;UBERON:0007687,1.06e-22,14;UBERON:0006554,9.33e-18,18;UBERON:0001008,7.63e-17,19;UBERON:0000489,2.81e-15,21;UBERON:0003103,1.31e-07,43 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.04103896362567,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.842666520790511,0,0,0,0,0,0,0,0,0,0,1.25602267690966,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228497025219458,1.1270773567308,0.407302655690628,0.387904974335251,0.771494018793504,6.70307293517127,16.5323365737154,17.1128613347099,24.4326384565165,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147198920134397,0,0,0,0,0,0,0,0,0,0,0,0.0985044823755635,0,0,0,0,0,0,0,0,0 | |||
|short_description=p3@Slc5a2 | |||
}} |
Revision as of 08:18, 4 August 2015
Short description: | p3@Slc5a2 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_3_at_Slc5a2_5end |
Coexpression cluster: | MCL_coexpression_mm9:11 |
Association with transcript: | 0bp_to_ENSMUST00000153418_5end |
EntrezGene: | 246787 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
kidney | 1.06e-22 | 14 |
kidney mesenchyme | 1.06e-22 | 14 |
upper urinary tract | 1.06e-22 | 14 |
kidney rudiment | 1.06e-22 | 14 |
kidney field | 1.06e-22 | 14 |
urinary system structure | 9.33e-18 | 18 |
renal system | 7.63e-17 | 19 |
cavitated compound organ | 2.81e-15 | 21 |
compound organ | 1.31e-07 | 43 |